{Reference Type}: Journal Article
{Title}: Influenza Vaccine Hesitancy among Cancer Survivors in China: A Multicenter Survey.
{Author}: Guo X;Han Q;Wang Y;Zhang R;Huang Y;Guo B;
{Journal}: Vaccines (Basel)
{Volume}: 12
{Issue}: 6
{Year}: 2024 Jun 8
{Factor}: 4.961
{DOI}: 10.3390/vaccines12060639
{Abstract}: <B>BACKGROUND: </B>Cancer survivors are at higher risk of developing severe complications from influenza due to their compromised immune systems. Despite their increased vulnerability to influenza and the availability of vaccines, vaccine hesitancy among cancer survivors remains a significant public health concern in China.<BR><B>METHODS: </B>A multicenter, cross-sectional study was conducted among cancer survivors in China from January to December 2023. A total of 500 participants were recruited from the oncology departments of five tertiary hospitals. A structured, self-administered questionnaire was used to collect data on socio-demographic characteristics, cancer-related information, medical history, lifestyle factors, and influenza vaccine hesitancy. Univariate and multivariate logistic regression analyses were performed to identify factors associated with influenza vaccine hesitancy.<BR><B>RESULTS: </B>The response rate was 97.0% (485/500). Among all participants, 204 (42.06%) reported vaccine hesitancy. The results of multiple logistic regression showed that the longer the end of anti-cancer treatment, without a history of adverse vaccine reactions, and the level of family support played a protective role in vaccine hesitancy. Current rehabilitation status, frequent colds, not being informed by doctors about vaccination, exercising, lack of community vaccination education programs, and concerns about vaccine safety were risk factors that increase vaccine hesitancy.<BR><B>CONCLUSIONS: </B>A high proportion of cancer survivors in our study reported influenza vaccine hesitancy. Addressing concerns about vaccine safety, improving access to vaccination services, and enhancing doctor-patient communication are crucial for increasing influenza vaccine uptake in this vulnerable population.